STOCK TITAN

NextPlat to Acquire Pensacola-Area Pharmacy, Expanding Florida Footprint and Adding Approximately $5.6 Million in Profitable Annual Revenue

(Positive)

NextPlat (NASDAQ: NXPL) agreed to acquire an independent pharmacy in a rural community near Pensacola, Florida, for total cash consideration of $1.5 million, including inventory. According to NextPlat, closing is expected in Q4 2026, subject to final due diligence and customary conditions.

The pharmacy has operated for over 25 years and generated approximately $5.6 million in 2025 sales with retail margins of about 19%, was profitable, maintained positive working capital, and had no debt. Once completed, the deal will extend NextPlat’s PharmcoRx retail footprint into an underserved northwest Florida market and support the rollout of same-day delivery, online fulfillment, and expanded contracted services for 340B providers, long-term care facilities, and other institutional and governmental customers. In 2025, NextPlat’s healthcare operations produced about $39.7 million of its $54.3 million in revenue, and the company targets roughly 20% organic healthcare growth in 2026.

Loading...
Loading translation...

Positive

  • $1.5 million cash deal for pharmacy with $5.6 million 2025 sales
  • Target pharmacy delivers retail margins of about 19% and was profitable
  • Expansion of PharmcoRx footprint into underserved northwest Florida rural market
  • Healthcare operations contributed $39.7 million of $54.3 million 2025 revenue
  • Company expects approximately 20% organic healthcare growth in 2026

Negative

  • Acquisition closing in Q4 2026 remains subject to due diligence and conditions
  • Transaction requires $1.5 million cash outlay for purchase and inventory

Market reaction after Pensacola-area pharmacy acquisition: NXPL -5.44% in the Jul 15 session

-5.44% 2.0x vol
13 alerts
-5.44% Session close to close
+14.3% Peak Tracked
-18.8% Trough Tracked
$18.93M Market Cap
2.0x Rel. Volume

In the Jul 15 session, NXPL declined 5.44%, reflecting a notable negative market reaction. Argus tracked a peak move of +14.3% during that session. Argus tracked a trough of -18.8% from its starting point during tracking. Our momentum scanner triggered 13 alerts that day, indicating notable trading interest and price volatility. Trading volume was elevated at 2.0x the daily average, suggesting increased selling activity.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -5.4% in the session following this news. A sharp selloff after this acquisition wou...
Analysis

The stock moved -5.4% in the session following this news. A sharp selloff after this acquisition would be consistent with the last tagged deal, which saw about a -7.8% reaction. With an effective resale shelf registering 2,097,011 shares, investors may remain focused on potential overhang even as the pharmacy adds profitable revenue.

Key Figures

Acquisition price: $1.5 million Pharmacy 2025 sales: $5.6 million Retail margin: 19% +5 more
8 metrics
Acquisition price $1.5 million Cash consideration for Pensacola-area pharmacy and inventory
Pharmacy 2025 sales $5.6 million Annual sales for year ended December 31, 2025
Retail margin 19% Pharmacy retail margins in 2025
Healthcare revenue $39.7 million NextPlat Healthcare Operations revenue in 2025
Total 2025 revenue $54.3 million NextPlat company-wide revenue in 2025
Expected organic growth 20% Company’s expected organic growth in 2026
Specialty pharmacies 4 Existing PharmcoRx specialty pharmacy locations in central and southern Florida
Operating history 25 years Duration the acquired pharmacy has served its local community

Previous Acquisition Reports

1 past event · Latest: Oct 01 (Positive)
Same Type Pattern 1 events
Date Event Sentiment 24h Move Catalyst
Oct 01 Acquisition completion Positive -7.8% Completion of merger making Progressive Care a wholly owned subsidiary.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Tag-specific acquisition news for NextPlat has previously coincided with single-digit share price declines.

Key Terms

340b drug pricing program, working capital, debt-free balance sheet
3 terms
340b drug pricing program regulatory
"healthcare providers participating in the government's 340B Drug Pricing Program, long-term"
A federal program that lets eligible hospitals and clinics buy outpatient prescription drugs at significant discounts, similar to a store offering bulk-price deals to certain shoppers. It matters to investors because those discounts affect how much drugmakers can charge, influence hospitals’ medication costs and margins, and shape pricing and reimbursement dynamics across the healthcare market, which can change revenue and profit forecasts.
working capital financial
"The Pharmacy was profitable, maintained positive working capital, and operated with a"
Working capital is the money a business has available to cover its daily expenses, like paying bills and buying supplies. It’s like the cash in your wallet that helps you handle everyday costs; having enough ensures the business can operate smoothly without running into money shortages.
View in glossary
debt-free balance sheet financial
"maintained positive working capital, and operated with a debt-free balance sheet."
A debt-free balance sheet means a company has no interest-bearing borrowings recorded on its balance sheet—no bank loans, bonds, or similar liabilities. Investors care because it changes the company’s cash obligations, risk profile and financial flexibility: like owning a house with no mortgage, the firm has fewer fixed payments and more freedom to use cash for operations, investment or returns, which can affect valuations and perceived stability.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Strategic Acquisition Enhances Pharmacy Diversification with Expansion into Underserved Northwest Florida Market, and Supports Launch of New High-Value Healthcare Services for Regional Providers and Patients

HALLANDALE BEACH, Fla., July 15, 2026 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide,today announced the strategic acquisition of an independent pharmacy ("the Pharmacy") in a rural community near Pensacola in the panhandle region of northwest Florida.

NextPlat Logo 1280 x 720 px - nextplat trademark Logo v3

NextPlat has agreed to acquire the Pharmacy and its inventory for total cash consideration of $1.5 million. The transaction is expected to be completed during Q4 2026, subject to final due diligence and other customary closing conditions. Once completed, the acquisition will expand and diversify the Company's PharmcoRx retail footprint into a previously underserved rural market where it intends to introduce additional offerings for patients including same day delivery and online fulfillment services to support the local community. The Company also plans to expand its contracted services reach by marketing to healthcare providers participating in the government's 340B Drug Pricing Program, long-term care facilities, and other institutional and governmental providers throughout the greater Pensacola area.

NextPlat's PharmcoRx unit currently operates four specialty pharmacies serving patients in central and southern Florida providing full-service prescription fulfillment, medication management, high-touch, same day delivery, and integrated patient support and coordination with healthcare providers. Beyond traditional retail pharmacy services, PharmcoRx also provides higher margin contracted services including medication fulfillment, claims management and compliance reporting to 340B providers as well as to long-term care, senior living communities and government agencies.

"This transaction expands PharmcoRx's business into a large, untapped market, creating immediate synergies including the roll-out of service enhancements for patients and serving as a growth platform for the introduction of our higher-margin contracted offerings for healthcare providers throughout the panhandle," said David Phipps, CEO of NextPlat. "Through additional acquisitions we are exploring, we believe we have a unique opportunity to not only differentiate the retail pharmacy experience in new markets but leverage these locations to support local engagement with additional healthcare providers and institutions that can benefit from our array of integrated services."

The Pharmacy, serving the local community for over 25 years, has provided customers with prescription medications fulfillment, over-the-counter (OTC) products, durable medical equipment, and healthcare advisory services in a rural market overlooked by the large national retail chains. For the year ended December 31, 2025, the Pharmacy generated approximately $5.6 million in sales with retail margins of approximately 19%. The Pharmacy was profitable, maintained positive working capital, and operated with a debt-free balance sheet.

NextPlat's Healthcare Operations generated approximately $39.7 million of the Company's $54.3 million in 2025 annual revenues. The Company expects organic growth of approximately 20% in 2026, supported by increases in higher margin 340B and contracted services, as it seeks to further expand and diversify its healthcare operations, replicating its model in additional underserved markets.

Rodney Barreto, Chairman of NextPlat Corp, added, "PharmcoRx has established itself as a premier community pharmacy, serving customers in South and Central Florida for over 20 years. Through acquisitions of rural operators, PharmcoRx is well positioned to pursue the many growth opportunities we see across Florida to deliver reliable, high-quality healthcare services in communities not adequately served by the large retail chains."

Additional information on this transaction may be found in the Current Reports on Form 8-K that will be filed by NextPlat with the U.S. Securities and Exchange Commission (the "SEC").

For more information about NextPlat, please visit www.NextPlat.com and connect with us on Facebook, LinkedIn and X.

About NextPlat Corp

NextPlat is a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to provide access to high quality healthcare and pharmacy services supporting patients, providers, institutions, and public-sector organizations and creating online sales channels for the sales of products to domestic and international consumers. Through its subsidiaries, NextPlat provides pharmacy and healthcare data management services and prescription fulfillment services in the United States and operates an e-commerce division offering voice, data, tracking, and IoT products and services worldwide.

Forward-Looking Statements

Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to successfully acquire and integrate pharmacies, and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (financial or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the SEC, copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.

Media and Investor Contact for NextPlat Corp:

Michael Glickman

MWGCO, Inc.

917-397-2272

mike@mwgco.net 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nextplat-to-acquire-pensacola-area-pharmacy-expanding-florida-footprint-and-adding-approximately-5-6-million-in-profitable-annual-revenue-302825868.html

SOURCE NextPlat Corp.

FAQ

What is NextPlat (NXPL) acquiring in northwest Florida in 2026?

NextPlat is acquiring an independent pharmacy near Pensacola for $1.5 million in cash. According to NextPlat, the deal includes the pharmacy and its inventory and is expected to close in Q4 2026, subject to due diligence and customary conditions.

How much revenue will the Pensacola-area pharmacy add to NextPlat (NXPL)?

The Pensacola-area pharmacy generated about $5.6 million in 2025 sales. According to NextPlat, the business delivered retail margins of approximately 19%, was profitable, maintained positive working capital, and operated without debt, potentially adding profitable revenue to the healthcare portfolio.

How does the Pensacola pharmacy acquisition affect NextPlat’s PharmcoRx footprint?

The acquisition expands PharmcoRx into a rural, underserved northwest Florida market near Pensacola. According to NextPlat, it complements four existing specialty pharmacies in central and southern Florida and supports new services such as same-day delivery and online fulfillment for local patients and providers.

What role do healthcare operations play in NextPlat (NXPL) revenues?

Healthcare operations generated about $39.7 million of NextPlat’s $54.3 million revenue in 2025. According to NextPlat, this segment is central to its growth strategy, and the company targets roughly 20% organic healthcare revenue growth in 2026 through expanded higher-margin contracted services.

What higher-margin services does NextPlat plan for the Pensacola-area pharmacy?

NextPlat plans to introduce higher-margin contracted services such as 340B medication fulfillment, claims management, and compliance reporting. According to NextPlat, the pharmacy will also support long-term care facilities and governmental or institutional providers throughout the greater Pensacola area.

When is the NextPlat (NXPL) Pensacola pharmacy acquisition expected to close?

The Pensacola-area pharmacy acquisition is expected to close in Q4 2026. According to NextPlat, completion is contingent on final due diligence and other customary closing conditions, and additional details will be provided in Form 8-K filings with the SEC.